-transparent.png){kind=logo}
Twelve volunteers with a complaint of chronic insomnia participated in a placebo-controlled, double-blind, crossover study of the effects of buspirone t.i.d. on sleep pattern and daytime function. The drug was tested alone and in combination with flurazepam or triazolam. Buspirone alone did not impair objective measures of daytime wakefulness or performance. Impaired alertness was seen the day after bedtime administration of flurazepam but not after triazolam; buspirone did not alter these effects. Buspirone did not affect the Multiple Sleep Latency Test, a sensitive measure of changes in daytime alertness.
Related Publications
W F Seidel, and
S A Cohen, and
N G Bliwise, and
W C Dement
September 1991,
The American journal of psychiatry,
W F Seidel, and
S A Cohen, and
N G Bliwise, and
W C Dement
January 1985,
Progress in neuro-psychopharmacology & biological psychiatry,
W F Seidel, and
S A Cohen, and
N G Bliwise, and
W C Dement
September 2006,
Indian journal of clinical biochemistry : IJCB,
W F Seidel, and
S A Cohen, and
N G Bliwise, and
W C Dement
April 1989,
The American review of respiratory disease,
W F Seidel, and
S A Cohen, and
N G Bliwise, and
W C Dement
January 1988,
Pharmacotherapy,
W F Seidel, and
S A Cohen, and
N G Bliwise, and
W C Dement
January 1984,
Clinical pharmacy,
W F Seidel, and
S A Cohen, and
N G Bliwise, and
W C Dement
April 1999,
Clinical pharmacokinetics,
W F Seidel, and
S A Cohen, and
N G Bliwise, and
W C Dement
October 2001,
Psychopharmacology,
W F Seidel, and
S A Cohen, and
N G Bliwise, and
W C Dement
September 1985,
Drug intelligence & clinical pharmacy,
W F Seidel, and
S A Cohen, and
N G Bliwise, and
W C Dement
November 1991,
Presse medicale (Paris, France : 1983),
